PREVALENCE OF SYMPTOMS OF SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) AND OF FLUORESCENT ANTINUCLEAR ANTIBODIES ASSOCIATED WITH CHRONIC EXPOSURE TO TRICHLOROETHYLENE AND OTHER CHEMICALS IN WELL WATER

被引:107
作者
KILBURN, KH
WARSHAW, RH
机构
[1] Environmental Sciences Laboratory, University of Southern California School of Medicine, Los Angeles, CA 90033, 2025 Zonal Avenue
关键词
D O I
10.1016/S0013-9351(05)80014-3
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Criteria for the recognition of systemic lupus erythematosus (SLE) were applied to 362 subjects exposed to trichloroethylene, trichloroethane, inorganic chromium, and other chemicals in water obtained from wells in an industrially contamined aquifer in Tuscon, Arizona. Their antinuclear autoantibodies were measured by fluorescence (FANA) in serum. Ten patients with clinical SLE and/or other collagen-vascular diseases were considered separately. Results were compared to an Arizona control group, to published series, and to laboratory controls. Frequencies of each of 10 ARA symptoms were higher in exposed subjects than in any comparison group except those with clinical SLE. The number of subjects with 4 or more symptoms was 2.3 times higher compared to referent women and men. FANA titers >1:80 was approximately 2.3 times higher in women but equally frequent in men as in laboratory controls. ARA score and FANA rank were correlated with a coefficient (cc) of .1251, r2 = .0205 (p < 0.036) in women and this correlation was almost statistically significant in men cc = .1282, r2 = .0253 (p < 0.059). In control men and women neither correlation was significant. Long-term low-dose exposure to TCE and other chemicals in contaminated well water significantly increased symptoms of lupus erthematosus as perceived by the ARA score and the increased FANA titers. © 1992 Academic Press, Inc.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 25 条
  • [1] TOXIC OIL SYNDROME - A SYNDROME WITH FEATURES OVERLAPPING THOSE OF VARIOUS FORMS OF SCLERODERMA
    ALONSORUIZ, A
    ZEAMENDOZA, AC
    SALAZARVALLINAS, JM
    ROCAMORARIPOLL, A
    BELTRANGUTIERREZ, J
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1986, 15 (03) : 200 - 212
  • [2] BLACK CM, 1983, LANCET, V1, P53
  • [3] PROCAINAMIDE-LYMPHOCYTE REACTIONS - A POSSIBLE EXPLANATION FOR DRUG-INDUCED AUTOIMMUNITY
    BLUESTEIN, HG
    REDELMAN, D
    ZVAIFLER, NJ
    [J]. ARTHRITIS AND RHEUMATISM, 1981, 24 (08): : 1019 - 1023
  • [4] COHEN A S, 1971, Bulletin on the Rheumatic Diseases, V21, P643
  • [5] SOUTHWESTERN INTERNAL MEDICINE CONFERENCE - DRUG-INDUCED LUPUS - CLINICAL SPECTRUM AND PATHOGENESIS
    CUSH, JJ
    GOLDINGS, EA
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1985, 290 (01) : 36 - 45
  • [6] DEFALQUE RJ, 1961, CLIN PHARMACOL THER, V2, P665
  • [7] SYSTEMIC LUPUS-ERYTHEMATOSUS IN COMMUNITY - INCIDENCE, PREVALENCE, OUTCOME, AND FIRST SYMPTOMS - HIGH PREVALENCE IN BLACK WOMEN
    FESSEL, WJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1974, 134 (06) : 1027 - 1035
  • [8] GANCZAREZUK L, 1986, ARTHRITIS RHEUM, V29, pS83
  • [9] INCOMPLETE LUPUS-ERYTHEMATOSUS
    GREER, JM
    PANUSH, RS
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (11) : 2473 - 2476
  • [10] THE HETEROGENEITY OF SEROLOGIC FINDINGS AND PREDISPOSING HOST FACTORS IN DRUG-INDUCED LUPUS-ERYTHEMATOSUS
    HUGHES, GRV
    RYNES, RI
    GHARAVI, A
    RYAN, PFJ
    SEWELL, J
    MANSILLA, R
    [J]. ARTHRITIS AND RHEUMATISM, 1981, 24 (08): : 1070 - 1073